Avidity Partners Management LP 13D/13G Filings for Oruka Therapeutics Inc. (ORKA)

Avidity Partners Management LP 13D and 13G filings for Oruka Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
7:38 pm
Purchase
2024-09-3013GOruka Therapeutics Inc.
ORKA
Avidity Partners Management LP790,926
2.300%
790,926increase
(New Position)
Filing